Kefir: A Potential Gut Microbiota Modulator: A Systematic Review of Human Interventional Studies
Open Access
- 26 April 2026
- journal article
- review article
- Published by Wiley in Microbiologyopen
- Vol. 15 (3) , e70297
Abstract
Kefir is a fermented dairy product containing live and active microbial culture, including lactic acid bacteria and yeast. Preclinical studies and narrative reviews have reported potential modulatory effects of kefir on gut microbiota composition. Despite this, there isn't yet a thorough analysis of human intervention studies that fills this gap of research. Therefore, the aim of this review is to examine the role of kefir consumption on gut microbiota composition in humans. Comprehensive research was conducted using three major databases including Web of Science, PubMed, and Scopus. The risk of bias was assessed using Cochrane risk‐of‐bias tool and Risk of bias of non‐randomized trials. The search resulted in 2743 studies, of which eight studies met our eligibility criteria. Overall, kefir resulted in minor changes in phyla and class levels. On the other hand, the Bifidobacterium genus increased in 3 out of 4 studies. Kefir‐specific bacterial species and strains were found in participants fecal samples suggesting colonization properties. Kefir consumption was associated with modest and heterogenous changes in gut microbiota composition. Proposed mechanisms include transient persistent of kefir‐associated taxa and modulation of the intestinal environment, although direct functional evidence in humans remains limited.Keywords
This publication has 56 references indexed in Scilit:
- Intestinal Short Chain Fatty Acids and their Link with Diet and Human HealthFrontiers in Microbiology, 2016
- The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probioticNature Reviews Gastroenterology & Hepatology, 2014
- Purification and characterization of bacteriocin produced by oral Lactobacillus paracasei SD1Anaerobe, 2014
- The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolismJournal of Lipid Research, 2013
- Dysbiosis in inflammatory bowel diseases: the oxygen hypothesisThe ISME Journal, 2013
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement2009
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Antimicrobial and healing activity of kefir and kefiran extractInternational Journal of Antimicrobial Agents, 2005
- Gnotobiotic Models for Study of the Microbial Ecology of Clostridium difficile and Escherichia coliThe Journal of Infectious Diseases, 1986